The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A randomized phase II study comparing oral S-1 plus 24-hour infusion of irinotecan (Iri) and bevacizumab (Bev) with FOLFIRI plus bevacizumab in patients with metastatic colorectal cancer (MCRC).
 
Sotaro Sadahiro
No Relationships to Disclose
 
Toshiyuki Suzuki
No Relationships to Disclose
 
Akira Tanaka
No Relationships to Disclose
 
Kazutake Okada
No Relationships to Disclose
 
Gota Saito
No Relationships to Disclose
 
Hiroshi Miyakita
No Relationships to Disclose
 
Takashi Ogimi
No Relationships to Disclose
 
Lin Fung Chan
No Relationships to Disclose